COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients
Completed
- Conditions
- Covid19
- Registration Number
- NCT04728828
- Lead Sponsor
- Centre Hospitalier de Cornouaille
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Inclusion Criteria:<br><br> - all in-center haemodialysis individuals eligible and voluntary to receive one of the<br> approved COVID-19 vaccines.<br><br>Exclusion Criteria:<br><br> - individuals under 18 years of age
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method antibody synthesis induced after Covid-19 vaccination (positive or negative)
- Secondary Outcome Measures
Name Time Method Lack of immunogenicity;COVID-19 incidence;Death during follow up;measure antibody response to vaccines in patient subgroup (diabetic patients, patients with auto-immune disease, patients with cancer, patients with an history of solid organ transplantation);Longevity of the antibody synthesis induced after Covid-19 vaccination;antibody synthesis induced after one injection of Covid-19 vaccine